T. Rowe Price Investment Management, Inc. Adaptive Biotechnologies Corp Transaction History

T. Rowe Price Investment Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $61,528 - $87,273	-9,940 Reduced 0.92%	1,070,588 $7.18 Million
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $3.22 Million - $4.17 Million	412,326 Added 61.71%	1,080,528 $9.54 Million
Q4 2022 Feb 14, 2023	SELL	$6.26 - $9.34 $22,536 - $33,624	-3,600 Reduced 0.54%	668,202 $5.11 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $4.37 Million - $8.51 Million	671,802 New	671,802 $4.78 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.